1688-0420

S1688-04202023000101302

10.29277/cardio.38.1.13

España

00 00 2023

38 1

2015 12 2 2

91-102

de Haro-Del Moral F.Milandri A 2017 38 24 24

1895-904

2017 135 14 14

1357-77

2021 42 16 16

1554-68

2021 74 2 2

149-58

2021 5 12 12

ytab473

2020 136 23 23

2620-7

2017 70 11 11

991-1004

1982 49 1 1

9-13

1977 62 5 5

677-86

2005 63 7 7

20-35

2022 4 4 4

458-70

2016 214

477-81

2014 114 7 7

1089-93

2020 13 3 3

2015 56 5 5

522-6

2013 18 2 2

157-62

2004 43 3 3

410-5

2018 71 25 25

2919-31

2022 159 2 2

78-84

2016 68 5 5

426-30

2021 96 11 11

2768-78

2020 128

140-6

2021 44 12 12

2092-9

2021 146

89-94

2013 167 5 5

2156-61

Defibrillators in Nonischemic Cardiomyopathy Treatment Evaluation Investigators 2008 117 25 25

3181-6

2012 14 6 6

872-6

2020 59

122-5

2020 6 4 4

351-61

2014 11 1 1

158-62

2001 24 8 8

1228-33

2009 104 7 7

990-4

2016 13 2 2

383-90

1997 30 4 4

1046-51

2009 120 13 13

1203-12

2019 30 11 11

2427-32

2015 36 18 18

1098-105

2021 10 13 13

2764

Bayés de Luna A.Martínez-Sellés M.Bayés-Genís A.Elosua R.Baranchuk A

2017 17 1 1

211

1988 59 4 4

498-500

2002 106 16 16

2091-7

Toulouse Amyloidosis Research Network collaborators 2019 26 3 3

128-38

2015 22 3 3

147-55